Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hainan Shennong Seed Industry Technology
300189
5
Shanghai Menon Animal Nutrition Technology
301156
US OptionsDetailed Quotes
JNJ250404C162500
- 0.01
- -0.16-94.12%
15min DelayClose Apr 4 16:00 ET
0.20High0.01Low
0.14Open0.17Pre Close3.65K Volume7.80K Open Interest162.50Strike Price13.92KTurnover1736.25%IV6.05%PremiumApr 4, 2025Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0080Delta0.0058Gamma15324.00Leverage Ratio-49.4821Theta0.0000Rho123.15Eff Leverage0.0000Vega
Johnson & Johnson Newsroom
Guggenheim Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Announces Target Price $166
Wells Fargo Adjusts Price Target on Johnson & Johnson to $170 From $152, Keeps Equalweight Rating
Barclays Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Maintains Target Price $166
Guggenheim Maintains Johnson & Johnson(JNJ.US) With Hold Rating
Johnson & Johnson Analyst Ratings
A Quick Look at Today's Ratings for Johnson & Johnson(JNJ.US), With a Forecast Between $171 to $185
Johnson & Johnson: Buy Rating Affirmed Amid Legal Challenges and Positive Growth Projections
TD Cowen Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $185
TD Cowen Reaffirms Their Buy Rating on Johnson & Johnson (JNJ)
Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Siemens Healthineers AG (OtherSEMHF)
TD Cowen Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $185
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $181
Johnson & Johnson (JNJ) Receives a Buy From RBC Capital
Guggenheim Maintains Johnson & Johnson(JNJ.US) With Hold Rating
Johnson & Johnson Analyst Ratings
Johnson & Johnson Is Maintained at Neutral by B of A Securities
Johnson & Johnson Analyst Ratings
BofA Securities Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $171
DBS Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Announces Target Price $170
Hold Rating for Johnson & Johnson Amid Patent Expiration Concerns and New Drug Developments
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now